North American dietary supplements market to reach $175B by 2036
Shoppers increasingly prefer targeted health products over traditional daily multivitamins, focusing on cognitive, gut, cardiovascular, and joint support.
Shoppers increasingly prefer targeted health products over traditional daily multivitamins, focusing on cognitive, gut, cardiovascular, and joint support.
Walgreens stated that the initiative aims to help lower tensions in tough situations and prevent disruptive behavior.
The expansion reflects rising consumer awareness of nutrition, immunity, wellness, and an aging population seeking products for chronic conditions and healthy aging.
U.S. retailers face growing demand for transparency in strain labeling and CFU counts among informed supplement consumers.
As AI-powered diagnostics, AR try-ons, and science-backed formulas continue to grow, U.S. retail will be a key driver in shaping global beauty innovation through 2032.
Patients can access weight management care for $49 per visit, no monthly subscription needed.
For U.S. retailers, probiotics are no longer limited to a niche supplement market.
The Vitamin Shoppe Supplement Awards honor the year's top brands and products, selected in partnership with the editors of Men's Health and Women's Health.
Construction is scheduled to begin in spring 2026, with the site expected to be fully operational by 2029.
Used by millions of patients worldwide, the KwikPen for single-patient use offers a new option for receiving Zepbound.
Using Simile’s AI simulations, CVS Health can test digital experiences in hours instead of weeks.
Bhattacharya will serve as acting director of the CDC while continuing to head NIH, marking the latest leadership shift within the Department of Health and Human Services.
Momentum in the U.S. grew driven by premium haircare, fragrance, and dermatologist-backed skincare.
In the U.S., growth is driven by mainstream retail and pharmacy channels, as sports nutrition products expand beyond specialty stores.
Beauty keeps outperforming many other consumer industries despite ongoing economic pressures.
As drugmakers implement 2026 price increases, SHARx argues that specialty pharmacy practices, not just list prices, often determine patient access and out-of-pocket costs.